Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 671 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Medivation, Astellas launch Xtandi capsules

Xtandi, an oral, once-daily androgen receptor inhibitor approved by the FDA, is being distributed through a network of specialty pharmacies and specialty distributors. Medivation co-founder, president and chief

Magellan launches drug management solution

Magellan Pharmacy Solutions president Tina Blasi said patients have received standard medications and specialty drugs in a disconnected and uncoordinated fashion. ”This lack of integration presents safety risks,

ScripsAmerica to acquire Marlex US facility

Marlex Pharmaceuticals’ s 12,000ft² facility contains temperature-controlled space and is used for pharmaceutical packaging, contract packaging and private labeling. The acquisition will increase revenues, order processing capability and

FDA approves Genzyme Aubagio MS therapy

Aubagio, an immunomodulator with anti-inflammatory properties, has shown significant efficacy across key measures of MS disease activity, such as reducing relapses, slowing the progression of physical disability, and

FDA approves GenMark RVP test

The eSensorRVP test simultaneously detects and differentiates 14 clinically relevant viruses from patients with influenza-like illness. The test will also improve patient care by delivering superior co-infection detection,